Efficacy of anterior chamber paracentesis after intravitreal triamcinolone injection
- PMID: 17932854
- DOI: 10.1177/112067210701700514
Efficacy of anterior chamber paracentesis after intravitreal triamcinolone injection
Abstract
Purpose: To investigate the efficacy of anterior chamber paracentesis for intravitreal triamcinolone acetonide injection (IVTA).
Methods: A prospective, randomized clinical trial was conducted on 30 eyes from 30 patients scheduled for IVTA (4 mg/0.1 mL). Eyes were randomly divided into two groups: eyes that had undergone anterior chamber paracentesis (Group 1, 15 eyes) and eyes that did not have anterior chamber paracentesis (Group 2, 15 eyes). Intraocular pressure (IOP) was measured by Goldmann applanation tonometry at a baseline of 2, 15, 30, and 60 minutes at 1 day and 1 week after the injection. The authors analyzed the short-term postoperative changes of the IOP in each group.
Results: For Group 1, the mean preoperative IOP was 15.33+/-1.72 mmHg, and the postoperative IOP at 2 and 15 minutes were 7.80+/-1.47 and 11.73+/-1.67 mmHg, respectively. For Group 2, there was a significant elevation of IOP (46.73+/-8.26 mmHg) 2 minutes after the injection, which decreased to the normal range (16.13+/-2.61 mmHg) by 15 minutes after the injection. There were no significant differences between the two groups in IOP at 15 minutes postsurgery compared with the distinct difference in IOP at 2 minutes post surgery (Student t-test, p=0.01).
Conclusions: The findings suggest that routine anterior chamber paracentesis is inappropriate due to the brief immediate postoperative IOP elevation with IVTA.
Similar articles
-
Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study.Graefes Arch Clin Exp Ophthalmol. 2017 Sep;255(9):1705-1712. doi: 10.1007/s00417-017-3702-1. Epub 2017 Jun 14. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28616715 Clinical Trial.
-
[Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection].Klin Monbl Augenheilkd. 2005 Aug;222(8):638-42. doi: 10.1055/s-2005-858459. Klin Monbl Augenheilkd. 2005. PMID: 16118744 German.
-
Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.Ophthalmology. 2006 Jul;113(7):1174-8. doi: 10.1016/j.ophtha.2005.10.061. Epub 2006 May 2. Ophthalmology. 2006. PMID: 16647122
-
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x. Acta Ophthalmol Scand. 2005. PMID: 16396641 Review.
-
Intravitreal triamcinolone acetonide: a change in a paradigm.Ophthalmic Res. 2006;38(4):218-45. doi: 10.1159/000093796. Epub 2006 Jun 6. Ophthalmic Res. 2006. PMID: 16763379 Review.
Cited by
-
Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study.Clin Ophthalmol. 2016 Jun 17;10:1131-8. doi: 10.2147/OPTH.S106096. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27382246 Free PMC article.
-
Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report.BMC Ophthalmol. 2017 Mar 14;17(1):25. doi: 10.1186/s12886-017-0417-3. BMC Ophthalmol. 2017. PMID: 28288603 Free PMC article.
-
Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection.Int J Ophthalmol. 2015 Jun 18;8(3):496-500. doi: 10.3980/j.issn.2222-3959.2015.03.11. eCollection 2015. Int J Ophthalmol. 2015. PMID: 26085997 Free PMC article.
-
Electroretinographic evaluations of retinal function before, just after, and after intravitreal injections.Sci Rep. 2016 Aug 5;6:31104. doi: 10.1038/srep31104. Sci Rep. 2016. PMID: 27492923 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical